低剂量阿司匹林预防后续妊娠小于胎龄儿出生的研究
瑞典登记队列研究纳入8416名首次妊娠分娩小于胎龄儿(SGA)的经产妇,801人(9.5%)在第二次妊娠使用低剂量阿司匹林。使用组SGA发生率21.7%与未使用组20.7%相近,校正后SGA风险(aRR 0.86,95%CI 0.67-1.10)及严重SGA风险(aRR 0.98,95%CI 0.71-1.34)均无显著关联。结论提示低剂量阿司匹林不应常规用于预防SGA复发。
要点
- 有SGA分娩史者再次妊娠使用低剂量阿司匹林,SGA发生率21.7% vs 20.7%,无显著差异。
- 低剂量阿司匹林与SGA(aRR 0.86,95%CI 0.67-1.10)及严重SGA(aRR 0.98,95%CI 0.71-1.34)风险无关。
- 合并子痫前期亚组中,低剂量阿司匹林同样未显示降低SGA或严重SGA风险。
核心结论
- 在有SGA新生儿分娩史的妇女中,低剂量阿司匹林与后续妊娠分娩SGA或严重SGA新生儿的风险降低无关。
- 这些发现提示不应使用低剂量阿司匹林来预防SGA复发。
研究设计与样本
- 瑞典登记为基础的队列研究,纳入有SGA新生儿(出生体重低于第10百分位)分娩史并进入第二次妊娠的妇女。
- 采用逆倾向加权估计,校正潜在混杂因素,分析后续妊娠使用低剂量阿司匹林与分娩SGA或严重SGA(出生体重低于第3百分位)新生儿的关联。
- 共8416名妇女在首次妊娠分娩SGA新生儿,其中801名(9.5%)在第二次妊娠期间使用低剂量阿司匹林。
主要发现
- 使用低剂量阿司匹林组SGA发生率为21.7%,未使用组为20.7%。
- 低剂量阿司匹林使用与SGA风险无关(aRR 0.86,95%CI 0.67-1.10),与严重SGA风险也无关(aRR 0.98,95%CI 0.71-1.34)。
- 在首次妊娠同时有SGA和子痫前期的妇女中,低剂量阿司匹林与SGA风险无关(aRR 0.83,95%CI 0.63-1.10),与严重SGA风险也无关(aRR 1.02,95%CI 0.73-1.44)。
- 在第二次妊娠发生子痫前期的妇女中,未观察到低剂量阿司匹林与SGA或严重SGA的关联。
临床怎么用
- 对于有SGA新生儿分娩史的妇女,低剂量阿司匹林未显示降低后续妊娠SGA或严重SGA的风险。
- 作者认为,这些发现提示不应使用低剂量阿司匹林来预防SGA复发。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To estimate whether low-dose aspirin use is associated with an altered risk of delivering a small-for-gestational age (SGA) neonate among women with a history of having an SGA neonate in a prior pregnancy. METHODS: We performed a Swedish register-based cohort study including women in their second pregnancy who had a history of having an SGA neonate (birth weight less than the 10th percentile). The association between use of low-dose aspirin in subsequent pregnancy and birth of an SGA neonate or a severely SGA neonate (birth weight less than the third percentile) were estimated using inverse propensity-weighted estimation, accounting for potential confounders. RESULTS: Among 8,416 women who gave birth to an SGA neonate in their first pregnancy, 801 (9.5%) used low-dose aspirin during their second pregnancy. The incidence of SGA neonates was similar among women using low-dose aspirin (21.7%) and those who did not use aspirin (20.7%). Low-dose aspirin use in pregnancy was not associated with an altered risk of having an SGA neonate (adjusted relative risk [aRR] 0.86, 95% CI 0.67-1.10) or a severely SGA neonate (aRR 0.98, 95% CI 0.71-1.34). Given the strong association between preeclampsia and SGA, we performed subgroup analyses based on preeclampsia status. Among women who had an SGA neonate and co-existing preeclampsia in their first pregnancy, low-dose aspirin was not associated with an altered risk of having an SGA (aRR 0.83, 95% CI 0.63-1.10) or severely SGA (aRR 1.02, 95% CI 0.73-1.44) neonate. Additionally, no association was seen among women who developed preeclampsia in their second pregnancy. CONCLUSION: Among women with a history of having an SGA neonate, low-dose aspirin was not associated with a decreased risk of having an SGA or severely SGA neonate in subsequent pregnancy. These findings suggest that low-dose aspirin should not be used to prevent recurrent SGA.
引用
- Hastie R, Tong S, Wikström AK, et al. Low-Dose Aspirin for Preventing Birth of a Small-For-Gestational Age Neonate in a Subsequent Pregnancy. Obstet Gynecol. 2022. PMID: 35271538. doi:10.1097/AOG.0000000000004696
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。